Join the Oncology Voice Network. Join for Free
The DARK Side of MSL-ing-What No One Tells YOU
Medical Science Liaison Key Opinion Leaders career journey challenges faced successful networking

The DARK Side of MSL-ing-What No One Tells YOU


Share This Article


Summary

In this episode, Kirsten Gurtowsky shares her experiences and insights as a Medical Science Liaison. She discusses her career journey, highlighting the balance and flexibility required in the MSL role, as well as the challenges faced. Kirsten delves into the importance of building strong relationships with Key Opinion Leaders and offers strategies for successful networking and engagement. She also provides guidance for aspiring MSLs, drawing on her professional experiences. The episode concludes with Kirsten sharing her excitement and goals for the upcoming year, followed by expressions of appreciation.

Kirsten Gurtowsky, Medical Science Liaison with Novartis, discusses the dark side of being an MSL and what you may not be aware of

Kirsten shares….

πŸ‘‰ What she LOVES about being an MSL
πŸ‘‰ What some of the main frustrations are for MSLs
πŸ‘‰ The challenges of travel and uncertainty
πŸ‘‰ The frustrations that come with paperwork and metrics
πŸ‘‰ Her insights and predictions for 2024

Click for Source
Medical Science Liaison, Key Opinion Leaders, career journey, challenges faced, successful networking

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN